New study into ‘smart drugs’ in the finance industry – Investment Magazine

A new article in Investment Magazine is inviting their readers to take part in our study investigating the use of so-called “smart drugs” in the Australian financial services industry. The BMM lab is conducting a survey investigating experience of the use of smart drugs (such a Ritalin or modafinil) for cognitive enhancement in the workplace.

The article can be accessed here.

The survey can be accessed here.